Sarah Beck
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disinfection | 13 | 2025 | 116 | 3.250 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 13 | 2024 | 83 | 2.790 |
Why?
| Water Purification | 9 | 2024 | 146 | 2.770 |
Why?
| Ultraviolet Rays | 10 | 2024 | 385 | 2.690 |
Why?
| Disinfectants | 2 | 2025 | 36 | 1.850 |
Why?
| Simian Immunodeficiency Virus | 12 | 2024 | 85 | 1.820 |
Why?
| Levivirus | 4 | 2025 | 18 | 1.810 |
Why?
| Virus Inactivation | 2 | 2025 | 11 | 1.200 |
Why?
| Virus Latency | 5 | 2019 | 90 | 1.150 |
Why?
| Macaca nemestrina | 7 | 2017 | 29 | 1.070 |
Why?
| Disease Models, Animal | 19 | 2024 | 3994 | 1.050 |
Why?
| Laundering | 1 | 2025 | 1 | 0.980 |
Why?
| Textiles | 1 | 2025 | 22 | 0.950 |
Why?
| Sodium Hypochlorite | 1 | 2024 | 5 | 0.950 |
Why?
| Monkeypox virus | 1 | 2024 | 13 | 0.940 |
Why?
| Macaca mulatta | 9 | 2024 | 153 | 0.930 |
Why?
| Water Microbiology | 4 | 2022 | 84 | 0.910 |
Why?
| Escherichia coli | 6 | 2024 | 782 | 0.880 |
Why?
| CD4-Positive T-Lymphocytes | 8 | 2020 | 1040 | 0.860 |
Why?
| RNA, Viral | 3 | 2016 | 622 | 0.800 |
Why?
| Virus Replication | 6 | 2019 | 448 | 0.770 |
Why?
| AIDS Dementia Complex | 3 | 2017 | 51 | 0.740 |
Why?
| Central Nervous System | 3 | 2018 | 254 | 0.730 |
Why?
| Vascularized Composite Allotransplantation | 4 | 2023 | 32 | 0.710 |
Why?
| HIV Infections | 7 | 2020 | 2696 | 0.660 |
Why?
| Germinal Center | 1 | 2019 | 54 | 0.650 |
Why?
| CD8-Positive T-Lymphocytes | 3 | 2019 | 824 | 0.620 |
Why?
| HIV-1 | 3 | 2019 | 840 | 0.600 |
Why?
| Histocompatibility Antigens Class I | 2 | 2016 | 196 | 0.560 |
Why?
| Macrophages | 7 | 2019 | 1452 | 0.560 |
Why?
| Viral Load | 9 | 2021 | 448 | 0.530 |
Why?
| SAIDS Vaccines | 1 | 2016 | 4 | 0.520 |
Why?
| Vaccines, Virus-Like Particle | 1 | 2016 | 3 | 0.520 |
Why?
| Gene Products, gag | 1 | 2016 | 36 | 0.510 |
Why?
| Microbial Viability | 1 | 2015 | 83 | 0.490 |
Why?
| Anti-Retroviral Agents | 5 | 2024 | 229 | 0.490 |
Why?
| DNA Damage | 2 | 2014 | 377 | 0.460 |
Why?
| Coronavirus Infections | 4 | 2021 | 355 | 0.450 |
Why?
| B-Lymphocytes | 1 | 2019 | 813 | 0.450 |
Why?
| Animals | 42 | 2024 | 34628 | 0.430 |
Why?
| Blood Platelets | 3 | 2024 | 369 | 0.430 |
Why?
| Skin Transplantation | 3 | 2024 | 87 | 0.420 |
Why?
| Adenoviridae | 1 | 2013 | 193 | 0.410 |
Why?
| Disease Susceptibility | 1 | 2015 | 338 | 0.410 |
Why?
| Cognitive Dysfunction | 1 | 2017 | 328 | 0.410 |
Why?
| Antiviral Agents | 1 | 2017 | 708 | 0.380 |
Why?
| Osteoma, Osteoid | 1 | 2011 | 4 | 0.380 |
Why?
| Graft Rejection | 5 | 2023 | 566 | 0.370 |
Why?
| Thoracic Vertebrae | 1 | 2011 | 72 | 0.360 |
Why?
| Hemostasis | 2 | 2024 | 68 | 0.360 |
Why?
| Tibia | 1 | 2011 | 183 | 0.330 |
Why?
| Hydrogen Peroxide | 2 | 2024 | 310 | 0.330 |
Why?
| Bone Neoplasms | 1 | 2011 | 227 | 0.310 |
Why?
| Middle East Respiratory Syndrome Coronavirus | 2 | 2019 | 8 | 0.300 |
Why?
| Skin | 3 | 2024 | 737 | 0.300 |
Why?
| Water | 2 | 2022 | 441 | 0.300 |
Why?
| Diarrhea | 2 | 2020 | 179 | 0.280 |
Why?
| Antibodies, Viral | 2 | 2021 | 598 | 0.270 |
Why?
| Calcium Signaling | 2 | 2020 | 236 | 0.250 |
Why?
| Monkey Diseases | 2 | 2016 | 23 | 0.250 |
Why?
| Detergents | 1 | 2025 | 45 | 0.240 |
Why?
| Heart Transplantation | 2 | 2022 | 713 | 0.240 |
Why?
| Thrombosis | 2 | 2020 | 331 | 0.240 |
Why?
| Pressure | 3 | 2014 | 238 | 0.240 |
Why?
| Wood | 1 | 2024 | 17 | 0.240 |
Why?
| Stainless Steel | 1 | 2024 | 23 | 0.230 |
Why?
| Glass | 1 | 2024 | 43 | 0.230 |
Why?
| Quaternary Ammonium Compounds | 1 | 2024 | 52 | 0.230 |
Why?
| Neuroticism | 1 | 2024 | 19 | 0.230 |
Why?
| CCR5 Receptor Antagonists | 2 | 2014 | 6 | 0.230 |
Why?
| Common Cold | 1 | 2024 | 14 | 0.230 |
Why?
| Cyclohexanes | 2 | 2014 | 22 | 0.220 |
Why?
| Surface Properties | 1 | 2024 | 391 | 0.210 |
Why?
| Neuroglia | 1 | 2024 | 165 | 0.210 |
Why?
| Nerve Regeneration | 1 | 2023 | 61 | 0.210 |
Why?
| Growth Hormone | 1 | 2023 | 96 | 0.210 |
Why?
| Humans | 27 | 2025 | 128896 | 0.210 |
Why?
| Personality | 1 | 2024 | 121 | 0.210 |
Why?
| Thrombocytopenia | 1 | 2024 | 187 | 0.200 |
Why?
| Regeneration | 1 | 2024 | 177 | 0.200 |
Why?
| Triazoles | 2 | 2014 | 153 | 0.200 |
Why?
| Organ Preservation Solutions | 1 | 2022 | 43 | 0.190 |
Why?
| Brain | 4 | 2019 | 2592 | 0.190 |
Why?
| Cricetinae | 4 | 2024 | 275 | 0.190 |
Why?
| Spinal Cord | 1 | 2024 | 360 | 0.190 |
Why?
| Wound Healing | 1 | 2024 | 308 | 0.190 |
Why?
| Myeloid Cells | 2 | 2019 | 140 | 0.190 |
Why?
| Hand Hygiene | 1 | 2020 | 8 | 0.180 |
Why?
| Dipeptidyl Peptidase 4 | 2 | 2019 | 13 | 0.180 |
Why?
| Myocutaneous Flap | 1 | 2020 | 11 | 0.180 |
Why?
| Superficial Back Muscles | 1 | 2020 | 14 | 0.180 |
Why?
| Disease Progression | 2 | 2020 | 2603 | 0.170 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 326 | 0.170 |
Why?
| Ethanol | 1 | 2024 | 577 | 0.170 |
Why?
| Mice | 13 | 2024 | 16543 | 0.170 |
Why?
| Hyperthermia, Induced | 1 | 2020 | 107 | 0.170 |
Why?
| Immunoconjugates | 1 | 2021 | 101 | 0.160 |
Why?
| Clinical Laboratory Techniques | 1 | 2020 | 86 | 0.160 |
Why?
| Severity of Illness Index | 4 | 2021 | 2767 | 0.160 |
Why?
| Recovery of Function | 1 | 2023 | 641 | 0.160 |
Why?
| Lung | 6 | 2021 | 3925 | 0.160 |
Why?
| Bacteroides fragilis | 1 | 2018 | 13 | 0.160 |
Why?
| Hindlimb | 1 | 2019 | 126 | 0.160 |
Why?
| Mammaplasty | 1 | 2020 | 96 | 0.150 |
Why?
| Soil | 1 | 2020 | 224 | 0.150 |
Why?
| Ventriculoperitoneal Shunt | 1 | 2018 | 37 | 0.150 |
Why?
| Equipment Contamination | 1 | 2018 | 57 | 0.150 |
Why?
| Fiducial Markers | 1 | 2018 | 8 | 0.150 |
Why?
| Agriculture | 1 | 2019 | 91 | 0.150 |
Why?
| Cone-Beam Computed Tomography | 1 | 2018 | 31 | 0.150 |
Why?
| Radiotherapy, Image-Guided | 1 | 2018 | 32 | 0.150 |
Why?
| Cross Reactions | 1 | 2018 | 129 | 0.150 |
Why?
| Th17 Cells | 1 | 2018 | 81 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 395 | 0.140 |
Why?
| Diastole | 2 | 2015 | 151 | 0.140 |
Why?
| Genome-Wide Association Study | 1 | 2024 | 1334 | 0.140 |
Why?
| Potassium Compounds | 1 | 2017 | 7 | 0.140 |
Why?
| Atrazine | 1 | 2017 | 8 | 0.140 |
Why?
| Clinical Decision-Making | 1 | 2020 | 311 | 0.140 |
Why?
| Swine | 4 | 2021 | 740 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 266 | 0.140 |
Why?
| Sulfates | 1 | 2017 | 49 | 0.140 |
Why?
| Inflammatory Bowel Diseases | 2 | 2018 | 311 | 0.140 |
Why?
| Male | 18 | 2024 | 63146 | 0.140 |
Why?
| Nanoparticles | 1 | 2020 | 358 | 0.130 |
Why?
| Receptors, Virus | 1 | 2016 | 81 | 0.130 |
Why?
| Sunlight | 1 | 2017 | 71 | 0.130 |
Why?
| Meningitis | 1 | 2017 | 81 | 0.130 |
Why?
| Syk Kinase | 1 | 2016 | 21 | 0.130 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2016 | 36 | 0.130 |
Why?
| Safety | 1 | 2018 | 325 | 0.130 |
Why?
| Encephalitis | 1 | 2017 | 130 | 0.130 |
Why?
| Colitis | 1 | 2018 | 240 | 0.130 |
Why?
| Gene Expression | 2 | 2024 | 1476 | 0.130 |
Why?
| Neurons | 1 | 2024 | 1425 | 0.130 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 267 | 0.130 |
Why?
| Immunotherapy | 1 | 2020 | 579 | 0.130 |
Why?
| Lymphocytes | 1 | 2017 | 369 | 0.130 |
Why?
| Arterial Occlusive Diseases | 1 | 2016 | 79 | 0.130 |
Why?
| Anti-Infective Agents | 1 | 2018 | 246 | 0.120 |
Why?
| Immune Evasion | 1 | 2016 | 54 | 0.120 |
Why?
| Mice, Transgenic | 4 | 2024 | 2073 | 0.120 |
Why?
| Tuberculosis, Pulmonary | 1 | 2016 | 135 | 0.120 |
Why?
| Mice, Inbred C57BL | 6 | 2024 | 5270 | 0.120 |
Why?
| Primary Cell Culture | 1 | 2016 | 159 | 0.120 |
Why?
| Viral Proteins | 1 | 2017 | 329 | 0.120 |
Why?
| Vitamin B 12 | 1 | 2016 | 120 | 0.120 |
Why?
| Cryptosporidium parvum | 1 | 2014 | 11 | 0.120 |
Why?
| Iron | 1 | 2017 | 285 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 361 | 0.120 |
Why?
| Pyridones | 1 | 2016 | 158 | 0.120 |
Why?
| Endometriosis | 1 | 2015 | 49 | 0.120 |
Why?
| Receptor, trkB | 1 | 2015 | 31 | 0.120 |
Why?
| Antitubercular Agents | 1 | 2016 | 195 | 0.120 |
Why?
| HIV Fusion Inhibitors | 1 | 2014 | 3 | 0.110 |
Why?
| Polymers | 1 | 2018 | 475 | 0.110 |
Why?
| Ventricular Dysfunction | 1 | 2014 | 15 | 0.110 |
Why?
| Neuroprotective Agents | 1 | 2015 | 110 | 0.110 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 110 | 0.110 |
Why?
| Water Pollutants, Chemical | 1 | 2017 | 204 | 0.110 |
Why?
| Ventricular Function | 1 | 2014 | 61 | 0.110 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 131 | 0.110 |
Why?
| Microglia | 1 | 2016 | 227 | 0.110 |
Why?
| Staphylococcal Infections | 1 | 2018 | 385 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 957 | 0.110 |
Why?
| Intestinal Mucosa | 1 | 2018 | 569 | 0.110 |
Why?
| Fibrinolytic Agents | 1 | 2016 | 264 | 0.110 |
Why?
| Extracellular Vesicles | 1 | 2015 | 123 | 0.110 |
Why?
| Myocardial Contraction | 1 | 2015 | 336 | 0.110 |
Why?
| Peripheral Nervous System Diseases | 1 | 2014 | 126 | 0.100 |
Why?
| Nasopharyngeal Diseases | 1 | 2012 | 5 | 0.100 |
Why?
| Sheep Diseases | 1 | 2012 | 7 | 0.100 |
Why?
| Alleles | 1 | 2016 | 847 | 0.100 |
Why?
| Bacteriophages | 1 | 2014 | 93 | 0.100 |
Why?
| Nasal Polyps | 1 | 2012 | 58 | 0.100 |
Why?
| Lizards | 1 | 2012 | 34 | 0.100 |
Why?
| Mesocricetus | 2 | 2021 | 38 | 0.100 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1967 | 0.090 |
Why?
| Cell Culture Techniques | 1 | 2013 | 350 | 0.090 |
Why?
| Radiography | 2 | 2011 | 863 | 0.090 |
Why?
| Colorectal Neoplasms | 1 | 2018 | 730 | 0.090 |
Why?
| Hydrogels | 1 | 2018 | 634 | 0.090 |
Why?
| Polymerase Chain Reaction | 1 | 2013 | 1045 | 0.090 |
Why?
| Mice, Nude | 2 | 2024 | 680 | 0.090 |
Why?
| Helicobacter Infections | 1 | 2010 | 28 | 0.090 |
Why?
| Pancreatic Neoplasms | 1 | 2018 | 878 | 0.090 |
Why?
| Carcinoma | 1 | 2012 | 214 | 0.090 |
Why?
| Rodent Diseases | 1 | 2010 | 26 | 0.080 |
Why?
| Protein Kinase Inhibitors | 1 | 2016 | 870 | 0.080 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 407 | 0.080 |
Why?
| Immunoglobulin M | 2 | 2021 | 268 | 0.080 |
Why?
| T-Lymphocytes | 1 | 2017 | 1905 | 0.080 |
Why?
| Heart Ventricles | 1 | 2014 | 778 | 0.080 |
Why?
| Breeding | 1 | 2008 | 62 | 0.080 |
Why?
| Mice, Knockout | 4 | 2018 | 2770 | 0.080 |
Why?
| Immunocompromised Host | 1 | 2010 | 198 | 0.080 |
Why?
| Spinal Diseases | 1 | 2008 | 48 | 0.080 |
Why?
| Intervertebral Disc | 1 | 2008 | 39 | 0.070 |
Why?
| Dog Diseases | 1 | 2008 | 52 | 0.070 |
Why?
| Thyroid Neoplasms | 1 | 2012 | 308 | 0.070 |
Why?
| Graft Survival | 2 | 2021 | 523 | 0.070 |
Why?
| Female | 12 | 2024 | 68162 | 0.070 |
Why?
| Bacteria | 1 | 2014 | 812 | 0.070 |
Why?
| Spleen | 2 | 2019 | 518 | 0.070 |
Why?
| Vaccination | 1 | 2016 | 1350 | 0.070 |
Why?
| Biomarkers | 2 | 2015 | 3874 | 0.070 |
Why?
| Chemokine CCL2 | 2 | 2019 | 122 | 0.070 |
Why?
| Immunoglobulin G | 2 | 2021 | 834 | 0.070 |
Why?
| Monocytes | 2 | 2019 | 553 | 0.070 |
Why?
| Cell Line, Tumor | 1 | 2013 | 3100 | 0.070 |
Why?
| Calcinosis | 1 | 2008 | 255 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2421 | 0.060 |
Why?
| Thrombopoiesis | 1 | 2024 | 8 | 0.060 |
Why?
| Megakaryocytes | 1 | 2024 | 32 | 0.060 |
Why?
| Platelet Factor 4 | 1 | 2024 | 33 | 0.060 |
Why?
| Mutation | 1 | 2016 | 3671 | 0.060 |
Why?
| Platelet Activation | 1 | 2024 | 85 | 0.060 |
Why?
| Toll-Like Receptors | 1 | 2024 | 182 | 0.050 |
Why?
| Feasibility Studies | 2 | 2018 | 859 | 0.050 |
Why?
| Rats, Inbred Lew | 1 | 2023 | 91 | 0.050 |
Why?
| Forelimb | 1 | 2023 | 28 | 0.050 |
Why?
| Dogs | 2 | 2018 | 372 | 0.050 |
Why?
| Multifactorial Inheritance | 1 | 2024 | 148 | 0.050 |
Why?
| RNA, Transfer | 1 | 2024 | 131 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2021 | 1204 | 0.050 |
Why?
| Gluconates | 1 | 2022 | 5 | 0.050 |
Why?
| Disaccharides | 1 | 2022 | 18 | 0.050 |
Why?
| Axons | 1 | 2024 | 181 | 0.050 |
Why?
| Pandemics | 2 | 2021 | 1516 | 0.050 |
Why?
| Dextrans | 1 | 2022 | 82 | 0.050 |
Why?
| Acute Disease | 1 | 2024 | 978 | 0.050 |
Why?
| Gene Expression Regulation | 2 | 2024 | 2520 | 0.050 |
Why?
| Organ Preservation | 1 | 2022 | 92 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 82 | 0.050 |
Why?
| Perfusion | 1 | 2022 | 191 | 0.050 |
Why?
| Cells, Cultured | 2 | 2019 | 4048 | 0.050 |
Why?
| Abatacept | 1 | 2021 | 47 | 0.050 |
Why?
| Democratic Republic of the Congo | 1 | 2020 | 25 | 0.050 |
Why?
| Interferon-beta | 1 | 2021 | 88 | 0.050 |
Why?
| Magnetic Fields | 1 | 2020 | 22 | 0.040 |
Why?
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 28 | 0.040 |
Why?
| Stromal Interaction Molecule 1 | 1 | 2020 | 9 | 0.040 |
Why?
| Logistic Models | 2 | 2020 | 1963 | 0.040 |
Why?
| CTLA-4 Antigen | 1 | 2021 | 88 | 0.040 |
Why?
| Glutathione | 1 | 2022 | 333 | 0.040 |
Why?
| Serologic Tests | 1 | 2020 | 49 | 0.040 |
Why?
| Immunity | 1 | 2021 | 132 | 0.040 |
Why?
| Allografts | 1 | 2021 | 138 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 102 | 0.040 |
Why?
| Tissue Distribution | 1 | 2020 | 295 | 0.040 |
Why?
| Upper Extremity | 1 | 2021 | 95 | 0.040 |
Why?
| Immunoglobulin A | 1 | 2021 | 190 | 0.040 |
Why?
| Antibody Formation | 1 | 2021 | 284 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2015 | 1694 | 0.040 |
Why?
| Anti-Bacterial Agents | 1 | 2010 | 1701 | 0.040 |
Why?
| Chemokine CXCL10 | 1 | 2019 | 33 | 0.040 |
Why?
| Blood Cells | 1 | 2019 | 39 | 0.040 |
Why?
| Macaca | 1 | 2019 | 53 | 0.040 |
Why?
| Piperidines | 1 | 2021 | 186 | 0.040 |
Why?
| Tissue Donors | 1 | 2022 | 398 | 0.040 |
Why?
| Swine, Miniature | 1 | 2019 | 76 | 0.040 |
Why?
| Tacrolimus | 1 | 2020 | 145 | 0.040 |
Why?
| Symptom Assessment | 1 | 2020 | 127 | 0.040 |
Why?
| Trinitrobenzenesulfonic Acid | 1 | 2018 | 9 | 0.040 |
Why?
| Ischemia | 1 | 2022 | 396 | 0.040 |
Why?
| Adenomatous Polyposis Coli Protein | 1 | 2018 | 18 | 0.040 |
Why?
| Genome, Viral | 1 | 2019 | 131 | 0.040 |
Why?
| Inflammation | 2 | 2020 | 2694 | 0.040 |
Why?
| Diet, High-Fat | 1 | 2019 | 240 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 107 | 0.040 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2024 | 593 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 1230 | 0.040 |
Why?
| Estradiol | 1 | 2021 | 494 | 0.040 |
Why?
| Duodenum | 1 | 2018 | 69 | 0.040 |
Why?
| Feces | 1 | 2020 | 430 | 0.040 |
Why?
| Pyrimidines | 1 | 2021 | 444 | 0.040 |
Why?
| Carcinogenesis | 1 | 2018 | 200 | 0.030 |
Why?
| Virus Internalization | 1 | 2016 | 43 | 0.030 |
Why?
| Pyrazinamide | 1 | 2016 | 11 | 0.030 |
Why?
| Rural Population | 1 | 2020 | 504 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2016 | 129 | 0.030 |
Why?
| Isoniazid | 1 | 2016 | 59 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2016 | 279 | 0.030 |
Why?
| Rifampin | 1 | 2016 | 82 | 0.030 |
Why?
| Transgenes | 1 | 2016 | 180 | 0.030 |
Why?
| Mental Disorders | 1 | 2024 | 1024 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2020 | 699 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 1 | 2017 | 542 | 0.030 |
Why?
| Pancreas | 1 | 2018 | 307 | 0.030 |
Why?
| Biopsy | 1 | 2019 | 1093 | 0.030 |
Why?
| Drug Resistance, Bacterial | 1 | 2016 | 170 | 0.030 |
Why?
| Sex Factors | 1 | 2021 | 1947 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2018 | 877 | 0.030 |
Why?
| Rats | 1 | 2023 | 5236 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1542 | 0.030 |
Why?
| Species Specificity | 1 | 2016 | 566 | 0.030 |
Why?
| Reference Values | 1 | 2016 | 791 | 0.030 |
Why?
| Receptors, CCR5 | 1 | 2014 | 58 | 0.030 |
Why?
| Patch-Clamp Techniques | 1 | 2015 | 259 | 0.030 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2014 | 91 | 0.030 |
Why?
| Nerve Fibers | 1 | 2014 | 89 | 0.030 |
Why?
| Administration, Oral | 1 | 2016 | 783 | 0.030 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 60 | 0.030 |
Why?
| Cornea | 1 | 2014 | 109 | 0.030 |
Why?
| Host-Pathogen Interactions | 1 | 2016 | 348 | 0.030 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 339 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2016 | 1020 | 0.030 |
Why?
| Epidermis | 1 | 2014 | 156 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 1545 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2014 | 111 | 0.030 |
Why?
| Cytokines | 1 | 2021 | 1995 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2020 | 3042 | 0.030 |
Why?
| Animals, Zoo | 1 | 2012 | 12 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2016 | 1194 | 0.020 |
Why?
| Plasma | 1 | 2013 | 198 | 0.020 |
Why?
| Ligands | 1 | 2014 | 614 | 0.020 |
Why?
| Analysis of Variance | 1 | 2015 | 1283 | 0.020 |
Why?
| Thyroxine | 1 | 2012 | 62 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2016 | 1968 | 0.020 |
Why?
| Signal Transduction | 2 | 2016 | 4857 | 0.020 |
Why?
| Hypothyroidism | 1 | 2012 | 71 | 0.020 |
Why?
| Receptors, Cell Surface | 1 | 2013 | 379 | 0.020 |
Why?
| Thyroid Gland | 1 | 2012 | 94 | 0.020 |
Why?
| Hyperplasia | 1 | 2012 | 171 | 0.020 |
Why?
| Child | 1 | 2011 | 20824 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 822 | 0.020 |
Why?
| Motor Activity | 1 | 2016 | 666 | 0.020 |
Why?
| Fatal Outcome | 1 | 2012 | 301 | 0.020 |
Why?
| Antigens, CD | 1 | 2013 | 479 | 0.020 |
Why?
| Genotype | 1 | 2016 | 1834 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 871 | 0.020 |
Why?
| Omeprazole | 1 | 2010 | 6 | 0.020 |
Why?
| Helicobacter | 1 | 2010 | 4 | 0.020 |
Why?
| Clarithromycin | 1 | 2010 | 28 | 0.020 |
Why?
| Metronidazole | 1 | 2010 | 20 | 0.020 |
Why?
| Complement Factor D | 1 | 2010 | 26 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2010 | 58 | 0.020 |
Why?
| Amoxicillin | 1 | 2010 | 31 | 0.020 |
Why?
| Myocytes, Cardiac | 1 | 2014 | 484 | 0.020 |
Why?
| Sheep | 1 | 2012 | 832 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2016 | 1694 | 0.020 |
Why?
| Chronic Disease | 1 | 2016 | 1715 | 0.020 |
Why?
| Hemodynamics | 1 | 2015 | 1095 | 0.020 |
Why?
| Drug Combinations | 1 | 2010 | 327 | 0.020 |
Why?
| Prospective Studies | 1 | 2020 | 7060 | 0.020 |
Why?
| Calcium | 1 | 2015 | 1173 | 0.020 |
Why?
| Case-Control Studies | 1 | 2016 | 3334 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2020 | 5355 | 0.020 |
Why?
| Phenotype | 1 | 2016 | 3059 | 0.020 |
Why?
| Child, Preschool | 1 | 2020 | 10457 | 0.020 |
Why?
| Risk Factors | 1 | 2019 | 9792 | 0.020 |
Why?
| Time Factors | 1 | 2016 | 6568 | 0.020 |
Why?
| Aged | 1 | 2024 | 22035 | 0.010 |
Why?
| Treatment Outcome | 1 | 2016 | 10239 | 0.010 |
Why?
| Incidence | 1 | 2008 | 2634 | 0.010 |
Why?
| Longitudinal Studies | 1 | 2008 | 2668 | 0.010 |
Why?
| Age Factors | 1 | 2008 | 3133 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2008 | 2270 | 0.010 |
Why?
|
|
Beck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|